Social Media Ideas for Alan Cassels

<![CDATA[Solving Data Problems with Casual Human Biology: Q&A with Dr. Brent Richards]]>

A New Cancer Drug and the Nature of Scientific Discovery

Glen Campbell, who was a member of The Wrecking Crew, once remarked that he had worked hard for ten years to become an overnight success in 1967, with thanks to John Hartford.  Wit...

<![CDATA[The Advantages of Conducting Early-Phase Clinical Studies in Canada]]>

<![CDATA[What's Driving the Concentration of Blockbuster Drugs]]>

<![CDATA[Roadblocks and Hurdles for DTC Prescription Drug Ad Oversight: Q&A with Dan Troy]]>

<![CDATA[The Impact of Strict Oversight on DTC Prescription Drug Ads]]>

How drug marketing shapes what your doctor prescribes

In April 2025, Gilead Sciences paid $202 million to settle allegations that it paid kickbacks to doctors through speaker fees and lavish dinners in return for more written prescrip...

Peptides promise a shortcut — medicine doesn’t work that way

There is a version of this story that ends well.A class of molecules with genuine biological potential, freed from bureaucratic delay, reaches patients who need them, backed by sol...

Less Is More in Medicine

In modern medicine, the zeitgeist today seems to be captured in one word: “more.” We need more MRI machines, more screenings, more surgical interventions, more drugs, more doctors....

<![CDATA[The Gates Foundation: Perfectly Aligned Interests]]>

3 pharma conflicts of interest hiding in plain sight

1. Medical journals are going the way of newspapers, as in “extinct” Who remembers newspapers? Pre-smartphone compendiums of world and local events on paper that required reporters...

<![CDATA[Modernizing Market Access and Patient Support Services: Q&A with Cam Olig]]>

Senator questions Merck over patent strategy for blockbuster cancer drug Keytruda

In a letter, Sen. Maggie Hassan cited ICIJ's Cancer Calculus investigation and expressed concerns that the pharma giant is boosting profits at the expense of patients.

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

<![CDATA[Clinical Affairs as the Foundation of Substantiated Promotional Claims in the CGM Market]]>

How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation

That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasing...

<![CDATA[The Push at FDA to Tighten Oversight on DTC Prescription Drug Ads]]>

Magic Medicine?

I Was Scammed Buying GLP-1s Online. I’m Not Alone

Customers have complained that a telehealth network selling compounded GLP-1s has been ripping them off—even after it had to pay $5 million to clients as part of a settlement with...

My prescription for good health? Stay away from medication

A NEW book, How to Take Drugs, by pharmacologist Dr Nick Barber, argues that many common prescription drugs, from statins to aspirins to blood pressure medication, may not work, or...

<![CDATA[Inside the Expert Network Guiding TGN-S15 to Market]]>

Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data and case studies, Stephen highlights patt...

<![CDATA[Do You Think the CNPV Program has Delivered on It's Promises?]]>

<![CDATA[Targeting HPV’s Hidden Mechanism: Q&A with Sandra Coufal, MD]]>